Another intriguing target may be proliferating cell nuclear antigen (PCNA), which is thought to undergo a post-translational modification that is detected only in cancer and cancer precursor cells, as early as the DCIS stage (Gu et al., 2018). This evidence concerns the gene PCNA and ductal breast carcinoma in situ.